Galderma to Present Extensive New Clinical Data Across Its Portfolio of Neuromodulators, Fillers and Biostimulators at the IMCAS World Congress 2022

2022年06月02日 12:56:47 来自: (0)参与

Strong clinical data supporting Alluzience (abobotulinumtoxinA, ABO), the first liquid, ready-to-use neuromodulator as an effective and well-tolerated treatment for glabellar (frown) lines, with a rapid onset and long duration of action of up to six months
Data confirming that Dysport was consistently efficacious for the treatment of frown lines, was well tolerated and had a fast onset of effect across three trials with high patient satisfaction reported up to 6 months after injection in phase III trials
Phase IV data confirming the effectiveness and natural-looking effects with the Restylane range of hyaluronic acid fillers, with all patients achieving the aim of their treatment, whether it was projection or contouring/volumization with results that were natural-looking with high subject satisfaction
Presentation of the latest extension study for Sculptra, the original poly-L-lactic acid (PLLA) which demonstrated it to be well-tolerated and with long-lasting effectiveness until week 96 using reconstituted 8mL dilution.

ZUG, Switzerland--(BUSINESS WIRE)--Galderma will present a range of new clinical data and analyses across its portfolio during nine poster sessions and two symposia at the upcoming International Master Course on Aging Science (IMCAS) World Congress 2022 in Paris from June 3-5, 2022.

“At Galderma, we are committed to advancing dermatology for every skin story. The extensive series of oral and poster presentations with new data from across our portfolio demonstrates our drive for innovation across the industry. We will also be hosting two symposia with leading physicians, reinforcing our partnership with the aesthetics community as we present work completed with them to deliver holistic individualized treatments (HITs) for patients and the science and clinical experience behind our latest innovation Alluzience, the first ready-to-use neuromodulator”

Flemming Ørnskov, M.D., MPH

Chief Executive Officer

Galderma

 
相关新闻
天涯网友:ゆ.咬破红唇
评论:木纳这事,如果干的好,叫深沉

天猫网友:理战  Free
评论:唐僧骑的是神马 , 悟空腾的是浮云 , 八戒爱的是小月月 , 沙僧装的是犀利哥 。

搜狐网友:听ヽ天甾哭泣
评论:命是爸妈给的,珍惜点;路是自己走的,小心点。

凤凰网友:醉眼的迷蒙.heart2/2
评论:有些人,认真的让你心疼,有些人,欠扁的让你牙疼

其它网友:心悲 2/2star°
评论:人生如梦,我总失眠;人生如戏,我总穿帮;人生如歌,我总跑调;人生如战场,我总走火。

淘宝网友:怀念旧时光°
评论:好名声是女人最体面的嫁妆。

本网网友:續寫這段情
评论:我们这个年龄,更多的是练爱而不是恋爱。

腾讯网友:资本、principal
评论:对于男人而言,前女友就好象是亲生的,后女友就像是领养的。

百度网友:我无力的趴下
评论:当今社会别结婚,结了又离多麻烦.

猫扑网友:不三姑娘 #
评论:职场三定律;:要么忍!要么狠!要么滚!

新闻转自网络媒体,如有侵权,请与我们联系:1160322105@qq.com责编:admin